Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Lonza Group AG LZAGF OTC

Other OTC • Healthcare • Medical - Diagnostics & Research • CH • USD

SharesGrow Score
65/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Lonza Group AG (LZAGF) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is bullish — 1 Buy.

LZAGF Analyst Ratings

Buy
1
Ratings
1 Buy
Based on 1 analysts giving stock ratings to Lonza Group AG in the past 3 months
Rating breakdown
Buy
1 100%
100%
Buy
1 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

People Also View

TMO
TMO
Thermo Fisher Scientific Inc.
$531.67
+0.84%
 DHR
DHR
Danaher Corporation
$198.14
-0.24%
 IDXX
IDXX
IDEXX Laboratories, Inc.
$580.76
-0.56%
 A
A
Agilent Technologies, Inc.
$119.77
-0.51%
 ILMN
ILMN
Illumina, Inc.
$132.26
+1.49%
 WAT
WAT
Waters Corporation
$326.20
-1.44%
 CRL
CRL
Charles River Laboratories International, Inc.
$180.56
+0.70%
 QGEN
QGEN
Qiagen N.V.
$41.64
-0.29%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message